A complete list of all programs within the Department of Environment, Great Lakes, and Energy (EGLE)
Community involvement and public participation are an essential part of EGLE’s mission, vision, and values.
SARA Title III establishes requirements regarding emergency planning and "Community Right-to-Know" reporting on hazardous and toxic chemicals for federal, state, local, and tribal governments, as well as regulated facilities.
Resources and information on utilizing RRD's data exchange and the Inventory of Facilities.
An interactive map displaying contaminated sites throughout Michigan regulated under Parts 213, 201, and 211.
The Michigan Department of Environment, Great Lakes, and Energy’s (EGLE) Water Well Viewer (WWV), is an interactive mapping system that displays water wells along with other information, such as wellhead protection areas, underground storage tanks, and sites of environmental contamination. Water well locations have been identified by address matching, the use of global positioning systems (GPS), and by legal descriptions.
This system allows water well drilling and pump installation contractors to submit water well records.
EGLE's interactive calendar is designed to provide timely information on decisions before the Director, proposed settlements of contested cases, administrative rules promulgation, public hearings, meetings and comment deadlines, and environmental conferences, workshops and training programs.
Anyone wishing to formally serve legal documents upon the Department of Environment, Great Lakes, and Energy (EGLE), or its officers or employees, may do so by the following methods.
Search is currently unavailable. Please try again later.
The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
The U.S. Environmental Protection Agency issued rules for healthcare providers on handling hazardous waste pharmaceuticals (HWP) on February 22, 2019. The rules became effective on August 21, 2019, and at that time, prohibited the disposal of pharmaceuticals down the drain. The rules were enacted to protect drinking water and surface water and were expected to reduce the amount of hazardous waste pharmaceuticals entering U.S. waterways by as much as 2,300 tons annually.
Healthcare providers subject to the federal sewering prohibition include any person lawfully authorized to:
Healthcare providers should talk with their current waste vendor or a vendor specializing in pharmaceutical waste handling and disposal to ensure they have provisions in place to properly handle unwanted pharmaceuticals. To learn more about Michigan’s pharmaceutical waste regulations and the federal rule, visit Michigan.gov/EGLEDrugDisposal and review "Non-Household Drug Disposal" resources. For questions regarding these environmental regulations, please e-mail EGLE-DrugDisposal@Michigan.gov.
Healthcare providers include, but are not limited to:
Pharmaceuticals generally include most formulations that have a National Drug Code. They are specifically defined as chemical formulations intended to diagnosis, cure, mitigate, care for, treat, or prevent disease or injury. They also include products intended to affect the structure or function of the body of a human or animal. This includes prescription drugs, over-the-counter drugs, and dietary supplements.
Michigan adopted the federal rules specific to healthcare facilities generating HWP on April 28, 2025. Those rules became effective on May 5, 2025.
As required by the federal mandate, those rules eliminated Michigan’s designation of pharmaceuticals as a universal waste. The adopted rules exclude HWPs that are a controlled substance from being subject to hazardous waste regulations if they are managed to meet the Drug Enforcement Administration (DEA) regulations. Inventories of controlled substances managed through a DEA registered reverse distributer are no longer subject to Michigan’s hazardous waste regulations.
Wastage - The wasting of leftover, unadministered partial doses of controlled substances, like a dose that remains in a vial, tube, transdermal patch, or syringe should be:
Collected wastage is no longer regulated by DEA if the controlled substances were administered to patients and the leftover pharmaceutical wasting was witnessed and documented. Consequently, wasting containers remain subject to hazardous waste regulation unless the healthcare provider has adequate waste characterization for all wastage accumulated in the container and can prove it includes only non-hazardous pharmaceuticals.
Controlled Substances Inventories Sent for Reverse Distribution and Disposal in accordance with DEA Regulations – Inventories of controlled substances that can no longer be administered to a patient and are sent for manufacturer credit through a DEA registered reverse distributor are no longer subject to the hazardous waste regulations. The transfer to the DEA registered reverse distributor or DEA registered disposal facility is considered a distribution under the DEA regulations and requires recordkeeping.
